Home - Products - Angiogenesis - PDE - Mirodenafil dihydrochloride

Mirodenafil dihydrochloride

CAS No. 862189-96-6

Mirodenafil dihydrochloride ( SK-3530 dihydrochloride )

Catalog No. M24857 CAS No. 862189-96-6

Mirodenafil dihydrochloride is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 53 In Stock
10MG 80 In Stock
25MG 138 In Stock
50MG 222 In Stock
100MG 380 In Stock
500MG 861 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mirodenafil dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Mirodenafil dihydrochloride is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.
  • Description
    Mirodenafil dihydrochloride is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.
  • Synonyms
    SK-3530 dihydrochloride
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    862189-96-6
  • Formula Weight
    604.6
  • Molecular Formula
    C26H39Cl2N5O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (165.40 mM)
  • SMILES
    [H]Cl.[H]Cl.O=C1C(N(CC)C=C2CCC)=C2N=C(C3=CC(S(=O)(N4CCN(CCO)CC4)=O)=CC=C3OCCC)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Paick, J.S., et al., Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction. J Sex Med, 2008. 5(11): p. 2672-80.
molnova catalog
related products
  • FCPR03

    FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively.

  • Icariin

    Icariin(Ieariline) is a major constituent of flavonoids from the Chinese medicinal herb Epimedium brevicornum.

  • Enoximone

    Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.